7 Nov 2019 11:22
7 November 2019
Serco Group plc
Legal Entity Identifier: 549300PT2CIHYN5GWJ21
Β
Β
Β
INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMRs') IN ACCORDANCE WITH ARTICLE 19 OF THE EU MARKET ABUSE REGULATION 596/2014
Β
On 4 November 2019, Kevin Craven exercised nominal-cost options, granted under the 2009 Serco Performance Share Plan. In connection with the exercise, Ordinary Shares of 2 pence each ('Ordinary Shares') were sold to satisfy tax liabilities and dealing costs. A summary of the Ordinary Shares acquired, sold and retained is set out below.
Β
Name of PDMR | Grant date of award | Vest date of award | Number of options exercised | Ordinary Shares sold to cover costs | Share price | Number of Ordinary Shares retained |
Kevin Craven, CEO UK and Europe | 6 April 2016 | 8 April 2019 | 326,711 | 156,314 | 156.6 pence | 170,397 |
Β
The notification of dealing forms for these transactions can be found below.
Β
Transaction notification
Β
Β
1 Β | Details of the person discharging managerial responsibilities / person closely associated Β | |||||
a) Β | Name | Kevin Craven | ||||
2 Β | Reason for the notification Β | |||||
a) Β | Position/status Β | CEO, UK and Europe | ||||
b) Β | Initial notification /Amendment Β | Initial notification | ||||
3 Β | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor Β | |||||
a) Β | Name Β | Serco Group plc ('the Company') | ||||
b) Β | LEI Β | 549300PT2CIHYN5GWJ21 | ||||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β | |||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of 2 pence each ('Ordinary Shares') Β | ||||
Β | Β | |||||
Identification code | ISIN: GB0007973794 | |||||
Β | Β | |||||
b) Β | Nature of the transaction Β Β | The exercise of nominal-cost options over Ordinary Shares granted on 6 April 2016 under the Company's 2009 Performance Share Plan. Β | ||||
c) Β | Price(s) and volume(s) |
Β | ||||
d) Β | Aggregated information | Β | ||||
Β | Β | |||||
- Aggregated volume | 326,711 | |||||
Β | Β | |||||
- Price | Β£6,534.22 | |||||
Β | Β | |||||
e) Β | Date of the transaction Β | 4 November 2019 | ||||
f) Β | Place of the transaction | N/A | ||||
4 Β | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted Β | |||||
a) Β | Description of the financial instrument, type of instrument | Ordinary Shares of 2 pence each ('Ordinary Shares') Β | ||||
Β | Β | |||||
Identification code | ISIN: GB0007973794 | |||||
Β | Β | |||||
b) Β | Nature of the transaction Β Β | The sale of Ordinary Shares to satisfy tax liabilities and dealing costs following the exercise of nominal-cost options over Ordinary Shares on 4 November 2019 under the Company's 2009 Performance Share Plan. Β | ||||
c) Β | Price(s) and volume(s) |
Β | ||||
d) Β | Aggregated information | Β | ||||
Β | Β | |||||
- Aggregated volume | 156,314 | |||||
Β | Β | |||||
- Price | Β£ 244,787.72 | |||||
Β | Β | |||||
e) Β | Date of the transaction Β | 4 November 2019 | ||||
f) Β | Place of the transaction | London Stock Exchange (XLON) | ||||
Β
Follow the stocks